ArticleMolecular and cellular pediatrics2026
Effects of preterm birth and gestational diabetes on innate lymphoid cells (ILCs) in human breast milk.
Article in Molecular and cellular pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreastfeeding provides key immunological and metabolic benefits for newborns, reducing complications of preterm birth and long-term risks associated with maternal gestational diabetes mellitus (GDM). However, the mechanisms underlying these protective effects, particularly the role of maternal immune cells in breast milk, remain incompletely understood. This study aimed to investigate how preterm birth and GDM influence the composition of breast milk-derived innate lymphoid cells (ILCs) during early lactation and to explore whether these maternal cells affect neonatal immune characteristics in vitro using cord blood T cells as a model system.
resultsBreast milk samples (colostrum and transitional milk) were collected within the first two weeks postpartum from mothers of term and preterm infants. Flow cytometric analysis revealed that total ILC frequencies decreased over time, with no significant differences between term and preterm deliveries. Colostrum from GDM mothers, however, contained significantly higher ILC frequencies compared with samples from normoglycemic controls, indicating that maternal metabolic status alters the immunological composition of breast milk. Cord blood T cells from GDM pregnancies showed elevated expression of the sphingosine-1-phosphate receptor 1 (S1PR1), suggesting an enhanced migratory phenotype. Co-culture experiments with breast milk-derived ILCs did not further increase S1PR1 expression or modify T cell activation markers (CD25, CD69, CTLA-4, PD-1). We emphasize that all functional assays were conducted in vitro using coculture systems with umbilical cord blood cells and were not performed directly on newborns.
conclusionsMaternal GDM modifies the composition of breast milk-derived ILCs and is associated with altered receptor expression on neonatal cord blood T cells. Nevertheless, in vitro exposure to breast milk ILCs did not enhance T cell activation, suggesting that breastfeeding may help maintain neonatal immune balance despite maternal metabolic stress. These results highlight a potential regulatory role of breast milk immune cells at the maternal-infant interface and underscore the importance of breastfeeding in mitigating pro-inflammatory programming in infants of GDM mothers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.